1. Home
  2. NVCR vs JAMF Comparison

NVCR vs JAMF Comparison

Compare NVCR & JAMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • JAMF
  • Stock Information
  • Founded
  • NVCR 2000
  • JAMF 2002
  • Country
  • NVCR Switzerland
  • JAMF United States
  • Employees
  • NVCR N/A
  • JAMF N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • JAMF Computer Software: Prepackaged Software
  • Sector
  • NVCR Health Care
  • JAMF Technology
  • Exchange
  • NVCR Nasdaq
  • JAMF Nasdaq
  • Market Cap
  • NVCR 1.4B
  • JAMF 1.4B
  • IPO Year
  • NVCR 2015
  • JAMF 2020
  • Fundamental
  • Price
  • NVCR $11.32
  • JAMF $7.40
  • Analyst Decision
  • NVCR Buy
  • JAMF Buy
  • Analyst Count
  • NVCR 7
  • JAMF 10
  • Target Price
  • NVCR $28.79
  • JAMF $16.90
  • AVG Volume (30 Days)
  • NVCR 1.7M
  • JAMF 1.3M
  • Earning Date
  • NVCR 07-24-2025
  • JAMF 08-07-2025
  • Dividend Yield
  • NVCR N/A
  • JAMF N/A
  • EPS Growth
  • NVCR N/A
  • JAMF N/A
  • EPS
  • NVCR N/A
  • JAMF N/A
  • Revenue
  • NVCR $630,160,000.00
  • JAMF $642,897,000.00
  • Revenue This Year
  • NVCR $6.15
  • JAMF $12.65
  • Revenue Next Year
  • NVCR $7.35
  • JAMF $9.02
  • P/E Ratio
  • NVCR N/A
  • JAMF N/A
  • Revenue Growth
  • NVCR 14.58
  • JAMF 10.75
  • 52 Week Low
  • NVCR $10.91
  • JAMF $7.37
  • 52 Week High
  • NVCR $34.13
  • JAMF $18.99
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 25.05
  • JAMF 26.75
  • Support Level
  • NVCR $10.91
  • JAMF $7.82
  • Resistance Level
  • NVCR $12.38
  • JAMF $8.43
  • Average True Range (ATR)
  • NVCR 0.93
  • JAMF 0.35
  • MACD
  • NVCR -0.49
  • JAMF -0.00
  • Stochastic Oscillator
  • NVCR 6.13
  • JAMF 3.12

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About JAMF Jamf Holding Corp.

Jamf Holding Corp is the standard in Apple Enterprise Management, and its cloud software platform is the vertically focused Apple infrastructure and security platform. The company helps organizations, including businesses, hospitals, schools, and government agencies, connect, manage, and protect Apple products, apps, and corporate resources in the cloud without ever having to touch the devices. It sells its Software-as-a-Service, or SaaS, solutions via a subscription model, through a direct sales force, online, and indirectly via its channel partners, including Apple. The company operates in The Americas; Europe, the Middle East, India, and Africa; and Asia Pacific.

Share on Social Networks: